A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH

Epilepsy Research

Volumn 93, Issue 2-3, 2011, Pages 149-154

  Zhu, Xiaobo ^a   Chen, Ou ^a   Zhang, Dongqing ^a   Jin, Ruifeng ^b   Li, Fuhai ^a   Wang, Yibiao ^b   Sun, Ruopeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Adrenocorticotropic hormone; Epilepsy; Infantile spasms; Topiramate

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; CORTICOTROPIN; POTASSIUM; TOPIRAMATE;

ANHIDROSIS; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSION; HYPOKALEMIA; INFANT; INFANTILE SPASM; INFECTION; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADRENOCORTICOTROPIC HORMONE; AGE OF ONSET; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SPASMS, INFANTILE; TREATMENT OUTCOME;

EID: 79251620182     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.12.002     Document Type: Article

References (40)

1. Baram T.Z., Mitchell W.G., Toumay A., Snead O.C., Hanson R.A., Horton E.J. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996, 97:375-379.
2. Buoni S., Zannolli R., Strambi M., Fois A. Combined treatment with vigabatrin and topiramate in infantile spasms. J. Child Neurol. 2004, 19:385-386.
3. Chiron C., Dumas C., Jambaqué I., Mumford J., Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997, 26:389-395.
4. Cowan L.D., Hudson L.S. The epidemiology and natural history of infantile spasms. J. Child Neurol. 1991, 6:355-364.
5. Glauser T.A., Clark P.O., Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998, 39:1324-1328.
6. Granström M.L., Gaily E., Liukkonen E. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms. Epilepsia 1999, 40:950-957.
7. Hamano S., Yamashita S., Tanaka M., Yoshinari S., Minamitani M., Eto Y. Therapeutic efficacy and adverse effects of adrenocorticotropic hormone therapy in west syndrome: differences in dosage of adrenocorticotropic hormone, onset of age, and cause. J. Pediatr. 2006, 148:485-488.
8. Hattori A., Ando N., Hamaguchi K., Hussein M.H., Fujimoto S., Ishikawa T., Togari H. Short-duration ACTH therapy for cryptogenic West syndrome with better outcome. Pediatr. Neurol. 2006, 35:415-418.
9. Heiskala H., Riikonen R., Santavuori P., Simell O., Airaksinen E., Nuutila A., Perheentupa J. West syndrome: individualized ACTH therapy. Brain Dev. 1996, 18:456-460.
10. Hosain S.A., Merchant S., Solomon G.E., Chutorian A. Tropiramate for the treatment of infantile spasms. J. Child Neurol. 2006, 21:17-19.
11. Hrachovy R.A., Frost J.D., Glaze D.G. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J. Pediatr. 1994, 124:803-806.
12. Hsieh M.Y., Lin K.L., Wang H.S., Chou M.L., Hung P.C., Chang M.Y. Low-dose topiramate is effective in the treatment of infantile spasms. Chang Gung Med. J. 2006, 29:291-296.
13. Ibrahim S., Gulab S., Ishaque S., Saleem T. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH-a developing country perspective. B.M.C. Pediatr. 2010, 10:1-9.
14. Ito M. Extremely low-dose ACTH therapy for West syndrome in Japan. Brain Dev. 2001, 23:635-641.
15. Ito M., Aiba H., Hashimoto K., Kuroki S., Tomiwa K., Okuno T., Hattori H., Go T., Sejima H., Dejima S., Ikeda H., Yoshioka M., Kanazawa O., Kawamitsu T., Ochi J., Miki N., Noma H., Oguro K., Ozaki N., Tamamoto A., Matsubara T., Miyajima T., Fujii T., Konishi Y., Okuno T., Hojo H. Low-dose ACTH therapy for West syndrome: initial effects and long-term outcome. Neurology 2002, 58:110-114.
16. Ito M., Seki T., Takuma T. Current therapy for West syndrome in Japan. J. Child Neurol. 2000, 15:424-428.
17. Ito M., Yu O., Chiu T.H. Interactions of ACTH4-10 and ACTH1-24 with l-[3H] glutamate binding sites and GABA/benzodiazepine/picrotoxin receptor complexes in vitro. Brain Dev. 1988, 10:106-109.
18. Kivity S., Lerman P., Ariel R., Danziger Y., Mimouni M., Shinnar S. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 2004, 45:255-262.
19. Korinthenberg R., Schreiner A. Topiramate in children with west syndrome: a retrospective multicenter evaluation of 100 patients. J. Child Neurol. 2007, 22:302-306.
20. Kurokawa T., Goya N., Fukuyama Y., Suzuki M., Seki T., Ohtahara S. West syndrome and Lennox-Gastaut syndrome. Pediatrics 1980, 65:81-88.
21. Kwon Y.S., Jun Y.H., Hong Y.J., Son B.K. Topiramate monotherapy in infantile spasm. Yonsei Med. J. 2006, 47:498-504.
22. Lux A.L., Osborne J.P. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 2004, 45:1416-1428.
23. Mackay M.T., Weiss S.K., Adams-Webber T., Ashwal S., Stephens D., Ballaban-Gill K., Baram T.Z., Duchowny M., Hirtz D., Pellock J.M., Shields W.D., Shinnar S., Wyllie E., Snead O.C. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004, 62:1668-1681. American Academy of Neurology, Child Neurology Society.
24. Nabbout R., Dulac O. Epileptic syndromes in infancy and childhood. Curr. Opin. Neurol. 2008, 21:161-166.
25. Nolte R., Christen H.J., Doerrer J. Preliminary report of a multicenter study on the West syndrome. Brain Dev. 1988, 10:236-242.
26. Oguni H., Yanagaki S., Hayashi K., Imai K., Funatsuka M., Kishi T., Osawa M. Extremely low-dose ACTH step-up protocol for West syndrome: maximum therapeutic effect with minimal side effects. Brain Dev. 2006, 28:8-13.
27. Privitera M.D. Topiramate: a new antiepileptic drug. Ann. Pharmacother. 1997, 31:1164-1173.
28. Riikonen R. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics 1982, 13:14-23.
29. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996, 37:367-372.
30. Shields W.D. West's syndrome. J. Child Neurol. 2002, 17:S76-S79.
31. Sidenvall R., Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia 1995, 36:572-574.
32. Takuma Y., Seki T. Combination therapy of infantile spasms with high-dose pyridoxal phosphate and low-dose corticotropin. J. Child Neurol. 1996, 11:35-40.
33. Trevathan E., Murphy C.C., Yeargin-Allsopp M. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 1999, 40:748-751.
34. Tsao C.Y. Current trends in the treatment of infantile spasms. Neuropsychiatr. Dis. Treat. 2009, 5:289-299.
35. Vigevano F., Cilio M.R. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997, 38:1270-1274.
36. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., Wolf H.H. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 1997, 28:167-179.
37. Wong M. Trevathan E. infantile spasms. Pediatr. Neurol. 2001, 24:89-98.
38. Yanagaki S., Oguni H., Hayashi K., Imai K., Funatuka M., Tanaka T., Yanagaki M., Osawa M. A comparative study of high dose and low-dose ACTH therapy for West syndrome. Brain Dev. 1999, 21:461-467.
39. Zou L.P., Ding C.H., Fang F., Sin N.C., Mix E. Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasms. Clin. Neuropharmacol. 2006, 29:343-349.
40. Zou L.P., Lin Q., Qin J., Cai F.C., Liu Z.S., Mix E. Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms. Clin. Neuropharmacol. 2008, 31:86-92. Topiramate Study Group.